Thor Medical ASA (FRA:8NN) Short Interest


FRA:8NN Thor Medical ASA FRA:8NN
21 GF Score
Price €0.39
! 2 Warning Signs
View Full Analysis

What is Thor Medical ASA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:8NN vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Thor Medical ASA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Short Interest distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Short Interest falls into.


FRA:8NN
21GF Score
Thor Medical ASA FRA:8NN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway0R6Y:UK
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
21GF Score

Get the complete analysis for FRA:8NN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.39
Price